Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.58 |
| ▸ | CCR1 | P32246 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | ELANE | P08246 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1951462 | 0.88 | SLC1A3 (0.69) | SLC1A3CCR1ALDH1A1MAPTGAA | |
| SCHEMBL1953003 | 0.88 | SLC1A3 (0.69) | SLC1A3CCR1ALDH1A1MAPTGAA | |
| SCHEMBL3363885 | 0.88 | SLC1A3 (0.69) | SLC1A3CCR1ALDH1A1MAPTGAA | |
| SCHEMBL7529238 | 0.87 | SLC1A3 (0.67) | SLC1A3CCR1ALDH1A1MAPTGAA | |
| SCHEMBL9421783 | 0.85 | SLC1A3 (0.56) | SLC1A3CCR1ALDH1A1MAPTGAA | |
| SCHEMBL15586449 | 0.85 | SLC1A3 (0.56) | SLC1A3CCR1ALDH1A1MAPTGAA | |
| SCHEMBL7529242 | 0.84 | SLC1A3 (0.55) | SLC1A3CCR1ALDH1A1MAPTGAA | |
| SCHEMBL16580217 | 0.83 | SLC1A3 (0.54) | SLC1A3CCR1ALDH1A1MAPTGAA | |
| SCHEMBL23240006 | 0.81 | SLC1A3 (0.54) | SLC1A3CCR1ALDH1A1MAPTGAA | |
| SCHEMBL1895598 | 0.80 | SLC1A3 (0.57) | SLC1A3ALDH1A1MAPTGAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150232509-A1 | SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150232509-A1 | SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS | HAVCR2, SLC10A1, SORD | SLC1A3 3256/4885CCR1 564/4885ALDH1A1 588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.